None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Those diagnosed with Parkinson's disease 2) Those who can communicate sufficiently with the tester and have a questionnaire and qualitative interview (in-depth interview) 3) Those who can follow-up during the clinical trial 4) After hearing the clear explanation of the purpose and characteristics of the clinical study, agree to participate and sign the consent form.
Exclusion criteria
Exclusion criteria: 1) Those who can not communicate normally 2) Those who refused to participate in clinical trials or to give consent. 3) Those who lack the ability to understand or express Korean. 4) Those judged to be inappropriate for clinical trials by the tester's judgment 5) Any other person deemed inadequate by the tester
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional measurement: walking balance evaluation, pulse wave analysis, blood stasis questionnaire;Questionnaire (quality of life, Unified Parkinson's Disease Rating Scale, Brief Symptom Inventory 18, Korean-Mini-Mental Status Examination, etc.), qualitative interview | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolites analysis | — |
Countries
Korea, Republic of
Contacts
Wonkwang University, Gwangju Medical Center